fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd

Updated on January 15, 2020

Stock/Share Code - TORNTPHARM

Torrent Pharmaceuticals is engaged in one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.

Below is the details of TORNTPHARM Torrent Pharmaceuticals Ltd

Market Cap₹32,128 Cr.
Current Price ₹1,824.95 as on 10 Dec 19
52 Week High / Low Price₹1,964 / ₹1,452
Face Value₹5
Stock P/E35.82
Book Value₹323.66
Dividend Yield0.90 %
ROCE13.09 %
ROE14.93 %
Sales Growth (3yrs)1.94 %
SectorPharmaceuticals
IndustryPharmaceuticals - Indian - Bulk Drugs & Formln
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company has reduced debt. Company has been maintaining a healthy dividend payout of 38.50%
Cons: Stock is trading at 5.87 times its book value The company has delivered a poor growth of 11.40% over past five years. Promoters have pledged 36.49% of their holding

Torrent Pharmaceuticals Ltd Price Chart

Torrent Pharmaceuticals Ltd Price Chart

Torrent Pharmaceuticals Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Sun Pharma.Inds. ₹170.05 24.93 ₹107,934.08 Cr. 0.61 ₹1,064.09 Cr. 57.62 17.09 8123.35 11.19
2. Dr Reddy's Labs ₹2,897.5 17.68 ₹48,412.38 Cr. 0.69 ₹1,106.8 Cr. 113.54 26.07 4812.80 12.42
3. Cipla ₹453.05 22.78 ₹37,626.53 Cr. 0.64 ₹474.5 Cr. 25.85 9.57 4395.78 10.94
4. Piramal Enterp. ₹1,611.6 17.30 ₹36,008.74 Cr. 1.43 ₹554.69 Cr. 17.26 14.61 3603.56 9.42
5. Biocon ₹289.65 43.30 ₹33,798 Cr. 0.18 ₹215.7 Cr. -24.60 19.02 1572.20 13.39
6. Torrent Pharma. ₹13.65 35.82 ₹32,128.11 Cr. 0.90 ₹328 Cr. 18.41 8.90 1603.00 13.09
7. Aurobindo Pharma ₹432.55 9.99 ₹26,361.38 Cr. 0.56 ₹639.86 Cr. 2.69 17.87 5600.47 18.45
8. Cadila Health. ₹260.95 16.83 ₹26,018.42 Cr. 1.38 ₹107.2 Cr. -35.02 13.69 3366.60 15.35

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Torrent Pharmaceuticals Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019
Sales1,2499628471,0251,0401,3321,4521,4721,4811,3571,6031,603
YOY Sales Growth %23.05%-2.83%-36.03%-3.12%-16.73%38.46%71.43%43.61%42.4%1.88%10.4%8.9%
Expenses9438527267897811,0401,0401,0161,0301,0631,0911,071
Material Cost %29.94%33.68%26.09%27.32%23.75%27.63%27.41%25.61%24.58%29.92%26.14%26.58%
Employee Cost %13.05%17.88%22.08%20.2%19.33%17.34%17.36%16.78%17.49%18.87%17.47%16.34%
Operating Profit306110121236259292412456451294512532
OPM %24%11%14%23%25%22%28%31%30%22%32%33%
Other Income71120109918151341081322731123
Interest4657555171117117120125119117111
Depreciation6876747889143141144147147149151
Profit before tax2639710119818083188300192255277393
Tax %11%-18%17%20%89%-165%35%8%5%36%19%17%
Net Profit2341148415820220122277182164223328
EPS in Rs13.786.794.979.311.2512.957.2116.3810.739.7313.1819.40
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019TTM
Sales9841,1651,4191,7502,0712,7603,3583,4685,4394,5514,2445,7626,044
Sales Growth %11.72%18.44%21.77%23.32%18.31%33.3%21.68%3.26%56.86%-16.33%-6.75%35.77%%
Expenses7839361,0401,3541,6802,0842,2982,6242,9913,4243,3374,1494,255
Material Cost %36.2%36.02%33.05%34.33%38.94%35.49%29.78%31.24%21.74%30.46%26.29%26.81%%
Manufacturing Cost %5.13%5.46%5.26%6.36%5.79%5.61%5.94%6.6%4.11%5.44%6.22%4.94%%
Employee Cost %11.23%10.89%11%15.54%14.93%13.27%12.47%14.63%10.52%15.36%19.46%17.6%%
Other Cost %27.06%27.96%24.02%21.14%21.48%21.15%20.22%23.2%18.62%23.97%26.65%22.66%%
Operating Profit2012293793963916761,0618432,4481,1279071,6131,789
OPM %20%20%27%23%19%24%32%24%45%25%21%28%30%
Other Income19381859849836306293300332382394
Interest21382939403758173180202294481472
Depreciation33375458647279180213269384579594
Profit before tax1661913143583716659587962,3489555629351,117
Tax %6%2%34%19%16%18%20%22%26%11%14%20%
Net Profit1561872072913115467626231,743854482745897
EPS in Rs8.8910.7011.7616.5417.7030.3643.3534.5794.5950.4728.4844.0553.04
Dividend Payout %19%18%24%23%23%36%22%31%34%28%49%39%

Compounded Sales Growth

  • 10 Years:: 17.33%
  • 5 Years:: 11.40%
  • 3 Years:: 1.94%
  • TTM:: 14.12%

Compounded Profit Growth

  • 10 Years:: 14.10%
  • 5 Years:: -1.16%
  • 3 Years:: -25.16%
  • TTM:: 40.38%

Return on Equity

  • 10 Years:: 24.99%
  • 5 Years:: 10.53%
  • 3 Years:: 10.98%
  • 1 Year:: 7.04%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Sep 2019
Share Capital42424242424285858585858585
Equity Capital42.3142.3142.3142.3142.3142.3184.6284.6284.6284.6284.6284.6284.62
Reserves5436908391,0511,2621,6092,2052,6213,6234,3694,4724,9315,392
Borrowings3424825225725796931,1322,5212,2492,4465,8455,6233,904
Other Liabilities3164114585717091,0329381,3021,4501,1521,4191,3892,688
Trade Payables163.83218.06261.66298.95373.4471.86517.9662.72739.29624.76816.98620.36665
Total Liabilities1,2431,6251,8612,2362,5923,3764,3606,5297,4068,05111,82012,02712,069
Fixed Assets4484875265886367918362,7642,6813,5237,4297,4257,332
Gross Block612.3680.79771.79884.93987.11203.881321.293416.053531.564634.198905.19465.64
Accumulated Depreciation164.78193.56246.16297.32350.8412.5485.13652.55850.171110.71476.572040.49
CWIP79461054427276508628984473447498516
Investments158245231431478190322434918936625486584
Other Assets5598489981,1731,4512,1182,6942,7042,8233,1193,3193,6183,637
Inventories166.53191.84227.88342.83393.13697.09694.51781.15970.131032.291299.41358.31360
Trade receivables198.48240.81259.78340.01409.61831.271317.431181.32911.51018.471108.041356.011547
Cash Equivalents97.67183.31346.79265.33366.68277.76218.4969.6882.3778.2257.09237.84160
Loans n Advances95.84231.57164.05141.49181.94234.44296.38435.15527.45629.17700.21445.4529
Other Assets etc00083.4799.9377.26167.23236.33331.75360.36154.37220.72541
Total Assets1,2431,6251,8612,2362,5923,3764,3606,5297,4068,05111,82012,02712,069

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Cash from Operating Activity227202307233396-693101,0652,4036769291,232
Profit from operations222.78262.22412.98425.37423.18769.351089.961112.682829.021410.751184.671755.9
Working Capital Changes24.62-42.8-44.1-123.3648.19-734.84-562.87-13.7463.75-479.84-123.25-315.89
Taxes paid-20.44-17.92-62.01-68.71-75-103.2-217.01-33.78-489.77-255.18-132.28-208.18
Cash from Investing Activity-139-31-137-242-142-89-326-2,099-584-527-4,207-373
Fixed Assets Purchased-121.15-50.94-150.21-241.17-83.29-294.63-364.45-176.13-466.82-471.78-755.7-615.8
Fixed Assets Sold3.120.851.061.91.151.281.815.796.970.591.141.78
Investments purchased-19.0200-0.95-17.5200000-15.25-2
Investments sold0.113.238.897.8711.368.6910.5415.92103.3672.8365.2160.79
Cash from Financing Activity350-4-69-1922586996-1,326-1302,929-928
Proceeds from Borrowings54.5120.31128.790.1138.3242.53426.741660.394901368.613899.36750
Repayment of Borrowings0-60.93-66.99-71.54-163.33-103.2-12.7-273.19-774.16-1129.87-488.06-1003.23
Interest Paid-19.35-26.02-25.97-28.17-30.6-30.71-60.83-192.42-201.96-187.87-263.69-480.01
Dividends Paid-0.11-33.19-41.01-59.12-137.34-83.44-267.39-199.69-839.7-203.67-264.77-309.69
Net Cash Flow123171165-7862-13370-3849319-349-69

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
ROCE %22%22%28%25%26%35%35%22%44%17%9%13%
Debtor Days747567717211014312461829586
Inventory Turnover5.586.506.766.135.635.064.834.706.214.553.644.34

Announcements & News

Recent Announcements

Annual Reports

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Torrent Pharmaceuticals Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.